Neoadjuvant Nivolumab Plus Gemcitabine/Cisplatin Chemotherapy in Muscle-Invasive Urothelial Carcinoma of the Bladder.

Hongsik Kim,Byong Chang Jeong,Joohyun Hong,Ghee Young Kwon,Chan Kyo Kim,Won Park,Hongryull Pyo,Wan Song,Hyun Hwan Sung,Jung Yong Hong,Se Hoon Park

Cancer research and treatment（2023）

引用 1|浏览9

暂无评分

摘要

Neoadjuvant N+GC was feasible and provided meaningful pathologic responses in patients with MIBC, regardless of baseline PD-L1 expression (ONO-4538-X41; CRIS.nih.go.kr, KCT0003804).

查看译文

关键词

Immunotherapy,Neoadjuvant therapy,Nivolumab,Urinary bladder neoplasms,Urothelial carcinoma

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要